The association with resistin, however, remained strong and significant after adjusting for BMI, suggesting that resistin may be an important biomarker of cancer mortality among Blacks above and beyond the influence of obesity and/or insulin resistance. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.